Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
-
Gramine for Ferroptosis and TNBC Research
2026-09-16
Gramine is a mechanistically informative ferroptosis inducer for dissecting the CUL3–MTDH axis in triple-negative breast cancer models. This workflow combines dose-response testing with orthogonal ferroptosis, target-engagement, ubiquitination, and rescue assays to distinguish pathway causality from nonspecific cytotoxicity.
-
AT13387 Workflows for Hsp90 Inhibition
2026-09-16
AT13387 combines high-affinity Hsp90 binding with a practical workflow for mapping client-protein loss, cell cycle arrest, and apoptosis in cancer models. This guide connects dose-response design, orthogonal cell-death assays, formulation control, and a carefully bounded insight from recent NINJ1–norovirus research.
-
Trichostatin A for Senescence and Cancer Epigenetics
2026-09-15
Trichostatin A (TSA) offers reversible control of HDAC activity for studying chromatin remodeling, breast cancer cell proliferation inhibition, differentiation, and senescence. This workflow connects TSA treatment with the mitochondrion-processed TERC-53 pathway while separating histone acetylation effects from telomerase-independent RNA signaling.
-
Matrine, YTHDF1, and Thymoma Stemness
2026-09-15
A 2026 study reports that Matrine reduces stemness-associated phenotypes and promotes apoptosis in EL-4-B5 thymoma cells, while implicating YTHDF1 and Wnt/β-catenin signaling. The work offers a focused in vitro framework for studying thymoma stemness, but the lack of direct m6A measurements, animal studies, target-RNA validation, and clinical samples limits causal and translational interpretation.
-
Podophyllotoxin Assays: Mechanism Before Measurement
2026-09-14
Podophyllotoxin is more than a cell-viability reagent: its microtubule biology demands mechanism-aware assay design. This guide distinguishes parent-compound effects from derivative-specific findings and builds a practical framework for cell-cycle, apoptosis, autophagy, and multidrug-resistance studies.
-
Brassinolide Workflows for Plant and Cell Assays
2026-09-14
Brassinolide supports a practical bridge between plant-growth bioassays and mechanistic PC-3 apoptosis studies. This guide covers solution handling, dose-range design, rice lamina inclination testing, cell-based readouts, diabetes-model interpretation, and troubleshooting.
-
Separating Growth Arrest from Cancer Cell Death
2026-09-13
Hannah R. Schwartz’s dissertation shows that relative viability and fractional viability capture different components of anticancer drug response: growth inhibition and cell killing. Its central practical contribution is a framework for interpreting both endpoints across time, improving assay selection and the biological conclusions drawn from in vitro cancer studies.
-
BCECF-AM for Intracellular pH Imaging
2026-09-12
BCECF-AM converts esterase activity into a ratiometric intracellular pH readout, making it useful for live-cell stress, secretion, and autophagy experiments. Its two-wavelength design is particularly valuable for connecting Arabidopsis vacuolar-acidification phenotypes with quantitative cell physiology.
-
Norovirus Co-opts NINJ1 for Selective NS1 Secretion
2026-09-11
Song and colleagues show that murine norovirus uses the membrane-rupture factor NINJ1 as a selective export route for the viral protein NS1, rather than relying solely on nonspecific cellular lysis. The study connects caspase-3 cleavage, NINJ1 recruitment to viral replication sites, and intestinal infection, providing a mechanistic framework for viral immune evasion.
-
0.4% Trypan Blue Solution: Practical Guide
2026-09-11
0.4% Trypan Blue Solution supports rapid cell viability measurement by separating unstained viable cells from blue-stained dead or membrane-damaged cells during counting workflows. It is intended for research use in cell culture and cytotoxicity assays, not for diagnostic or medical applications, and it cannot independently identify a specific death pathway.
-
OM-MSCs, Golgi Stress, and Stroke Recovery
2026-09-10
The reference study identifies a previously underdefined neuroprotective mechanism in which olfactory mucosa mesenchymal stem cells reduce Golgi apparatus stress after cerebral ischemia/reperfusion injury. Its data connect OM-MSC-derived PEDF with PI3K/Akt/mTOR signaling, reduced excessive autophagy, and improved control of GOLPH3-associated cellular injury, offering a mechanistic framework for future stroke research.
-
KU-60019: ATM Kinase Inhibitor Workflow
2026-09-10
KU-60019 enables controlled ATM kinase signaling pathway inhibition for glioma radiosensitization, survival-pathway analysis, and migration or invasion studies. Its strong kinase selectivity and defined solvent profile support reproducible combination experiments when dosing, radiation timing, and vehicle controls are handled carefully.
-
Peroxynitrite, Ca2+ Flux, and Cardiac Necroptosis
2026-09-09
Liu et al. identify a mechanistic cascade linking hyperhomocysteinemia to cardiac microvascular ischemia–reperfusion injury: Hcy and Cu2+ increase peroxynitrite, which drives ER stress, IP3R-dependent Ca2+ transfer, mitochondrial overload, and endothelial necroptosis. The study positions IP3R-mediated Ca2+ handling as an experimentally tractable intervention point while clarifying how microvascular injury may worsen acute cardiovascular outcomes.
-
VX-765: Designing Causal Inflammasome Assays
2026-09-09
VX-765 and its active metabolite VRT-043198 provide a downstream strategy for testing caspase-1 dependence in cytokine release and pyroptosis. This article connects product chemistry with CARD8 inflammasome biology and practical assay design across macrophage and lymphocyte models.
-
Capecitabine A8647: Reliable Assay Workflows
2026-09-08
This scenario-driven guide explains how Capecitabine (SKU A8647) can support more interpretable viability, proliferation, and cytotoxicity studies. It connects prodrug activation, tumor–stroma modeling, solution preparation, assay normalization, and vendor-quality checks to practical preclinical oncology workflows.